XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Xtant Medical Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$0.29+0.00 (+1.50%)

Close on Oct 19, 2026

Market cap: $40.82M
P/E (TTM): –
Dividend yield: –

Xtant Medical Holdings, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Cash & Equivalents	17	6.20	5.72	20	18	2.34	5.24	6.80	2.86	2.58	6.37	4.47	3.05	4.93	0.75	0.33	0.05
Cash & Short-Term Investments	17	6.20	5.72	20	18	2.34	5.24	6.80	2.86	2.58	6.37	4.47	3.05	4.93	0.75	0.33	0.05
Receivables	18	21	22	11	7.15	6.88	10	9.99	13	19	15	4.43	4.79	7.15	7.08	3.52	–
Inventory	30	39	37	17	18	21	16	17	22	26	23	9.56	11	13	8.48	5.44	–
Prepaid Expenses & Other	2.39	1.60	1.33	0.67	0.84	0.74	0.78	0.59	1.71	1.15	0.60	0.65	0.57	0.35	0.29	0.57	–
Total Current Assets	78	67	65	49	44	31	32	35	40	49	45	19	19	26	17	10	–
Property, Plant & Equipment	6.20	10	8.69	5.79	5.21	4.35	4.70	7.17	9.91	16	12	4.65	5.18	5.23	3.77	3.40	–
Gross Property, Plant & Equipment	28	30	28	24	22	21	20	20	21	24	17	9.53	10	9.57	7.47	–	–
Accumulated Depreciation	-22	-20	-20	-18	-17	-17	-16	-13	-11	-7.86	-5.43	-4.87	-4.97	-4.34	-3.69	–	–
Operating Lease Right-of-Use Assets	3.19	0.83	1.52	1.38	1.26	1.69	2.10	3.00	–	–	–	–	–	–	–	–	–
Goodwill	6.07	7.30	7.30	3.21	3.21	3.21	3.21	3.21	42	42	42	0	0	0.73	0.73	–	–
Intangible Assets	0.30	8.36	10	0.34	0.40	0.46	0.52	0.57	14	36	40	0.66	0.59	0.59	0.66	0.36	–
Deferred Tax Assets	–	–	–	–	–	–	–	–	–	–	18	0	0	-0.05	0.02	–	–
Other Long-Term Assets	0.13	0.10	0.14	0.20	0.29	0.40	0.39	0.79	0.73	0.83	0.79	1.60	1.82	1.13	0.49	0.01	–
Total Assets	94	94	93	60	55	41	43	46	106	144	141	28	29	34	23	16	–
Accounts Payable	3.84	7.92	7.05	3.49	2.62	2.95	2.19	6.47	9.32	10	9.39	3.88	2.77	4.00	2.65	2.26	–
Accrued Expenses	11	7.77	10	5.50	4.35	5.46	6.63	5.15	16	8.98	9.60	1.92	3.59	2.40	3.76	1.39	–
Current Portion of Long-Term Debt	3.50	–	–	2.33	–	17	–	–	–	–	0	0.05	0.05	0.05	1.63	0.23	–
Current Debt	3.50	–	–	2.33	–	17	–	–	–	0	0	0.05	0.05	0.05	1.63	0.23	–
Current Portion of Leases	0.62	0.70	0.83	0.46	0.46	0.42	0.39	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	2.18	0.40	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	29	29	23	15	11	26	9.39	12	26	31	21	8.48	9.65	8.69	11	14	–
Long-Term Debt	11	22	17	9.69	12	–	76	78	67	–	44	21	16	14	6.64	2.19	–
Long-Term Leases	2.67	0.17	0.76	0.97	0.84	1.30	1.73	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	3.29	0.87	1.59	1.43	1.30	1.73	2.12	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	0.01	0.04	0.02	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	0.01	–	0.23	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	43	51	41	26	24	27	87	90	164	151	132	36	33	30	18	16	–
Total Debt	15	22	17	12	12	17	76	78	67	0	44	21	16	15	8.27	2.42	–
Preferred Stock	–	–	–	–	–	0	–	–	0	0	0	0	0	0	0	–	–
Common Stock	–	–	–	–	–	0	–	–	0	0.00	0.00	0.00	0.00	0.00	0.00	0.00	–
Additional Paid-In Capital	305	303	294	278	266	245	179	171	86	85	82	63	57	52	45	36	–
Retained Earnings	-254	-259	-243	-244	-235	-230	-223	-215	-145	-93	-73	-71	-60	-48	-40	-37	–
Comprehensive Income & Other	–	-0.32	0.03	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	51	43	51	34	31	15	-44	-44	-59	-7.07	8.88	-7.77	-3.84	4.23	5.50	-0.62	4.68
Total Equity	51	43	51	34	31	15	-44	-44	-59	-7.07	8.88	-7.77	-3.84	4.23	5.50	-0.62	4.68
Total Liabilities & Equity	94	94	93	60	55	41	43	46	106	144	141	28	29	34	23	16	–
Shares Outstanding(shares)	140	139	130	109	87	78	13	13	1.51	1.44	12	6.68	5.34	4.29	4.08	3.70	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 59.4%
Operating margin: -9.6%
Net margin: -10.2%
Return on equity, FY2025: 10.6%

Financial strength

Current ratio: 2.16
Debt to equity: 0.28
Debt to assets: 13.8%
Cash to current liabilities: 32.9%

Valuation

P/E ratio: –
Price to sales: 0.37
Price to book: 1.02
Dividend yield: –